Guest Skeptic: Dr. Dan Lane has a Masters in Health Services Research at the University of Calgary, a Doctor of Philosophy in Clinical Epidemiology from the University of Toronto and is currently a medical student at the University of Calgary.

Dan is naturally a contrarian, he strives to understand first principles of conventions in medical research in order to identify and challenge poor practices that have become dogma. He is passionate about statistics and epidemiology and wants to share that passion by making these topics more practical and approachable for clinicians. Believing the key to proper interpretation of medical research does not begin with memorizing some arbitrary threshold for statistical significance, Dan hopes to contribute to the SGEM through sharing an understanding of what story the numbers are actually telling about the data. Dan has no funding whatsoever, and no associations with industry. He is currently a medical student at the University of Calgary.

Dan has some pet peeves when it comes to statistics there used and critical appraisals. We will do some more in depth SGEM Xtras on each of these issues.

* Absolute vs. Relative Estimates

* Effect Estimates and Not P-Values

* All Models are Wrong

* Predication vs. Classification

* Bayes No Frequentists

The purpose of this SGEM Xtra, beside to introduce a new SGEM faculty member, is also to announce we are adding a new segment to the SGEM. It is going to be called Statistically Significant.

We want to make the SGEM even better and address some of the criticisms from the ClinEpi world about clinicians trying to do critical appraisal. In order to do that we now have a Dr. Dan Lane PhD who will be commenting on each the SGEM episodes.

The first instalment of Statistically Significant segment will be on this weeks’ SGEMHOP looking at troponin testing in the elderly patients presenting with non-specific complaints (SGEM#280). Let me know what you think of this idea. We have a few more lined up and feedback is always appreciated. Send me an email [email protected]

Statistically Significant #280: Sensitivity and Specificity

Despite their dogmatic use in the literature, sensitivity and specificity have a number of limitations that are rarely considered or addressed in diagnostic test studies.

Sensitivity and Specificity are crude metrics, meaning they only look at the effect of a single measure and a single outcome. As crude measures they fail to incorporate any other information into their estimates, including potential confounders for the relationship between the test result and the outcome.

In this particular study, age is part of the primary objective for the study (geriatric patients) but is also a confounder of the relationship between troponin level (which may increase with age) and acute coronary syndrome risk (also increases with age). When confounders like age are present, crude measures will be influenced based on the prevalence of confounders in each the groups – for example, if there were more older patients in the troponin positive group, the estimates for sensitivity may be inflated.

Another limitation of sensitivity and specificity is they require a test result be classified as positive or negative. This is problematic when the real measure is a continuous measure, such as troponin. In the current study the test was considered “positive” if the troponin level was above the 99th percentiles for that enzyme. But this arbitrarily treats patients above or below the 99th percentile as homog...